Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.
They do clinical trials for new drugs, including a recent trial for a neutralizing antibody for SARS-CoV-2 for the treatment and prevention of COV19.
With earnings surprises the last two quarters and a Zacks estimate for a strong Q4, Medpace is on track to make a new all-time high.
As it approaches the all-time high, volatility is decreasing while volume is shrinking. There is not much selling going on, so a little demand will cause this to pop above the all-time high and accelerate from there.
Buy point is at 144.49 with a stop loss of 7.63% based on the 10d ATR (x2.7). Position size of R13.1.
Buy Point: 144.49
Stop Loss: 133.47
Position Size: R13.1
They do clinical trials for new drugs, including a recent trial for a neutralizing antibody for SARS-CoV-2 for the treatment and prevention of COV19.
With earnings surprises the last two quarters and a Zacks estimate for a strong Q4, Medpace is on track to make a new all-time high.
As it approaches the all-time high, volatility is decreasing while volume is shrinking. There is not much selling going on, so a little demand will cause this to pop above the all-time high and accelerate from there.
Buy point is at 144.49 with a stop loss of 7.63% based on the 10d ATR (x2.7). Position size of R13.1.
Buy Point: 144.49
Stop Loss: 133.47
Position Size: R13.1
Website: drewby.com
Twitter: twitter.com/drewrobbins
All ideas are for information purposes only. I may or may not invest in the stocks discussed. Before investing in any stock, do your research and trade using your rules.
Twitter: twitter.com/drewrobbins
All ideas are for information purposes only. I may or may not invest in the stocks discussed. Before investing in any stock, do your research and trade using your rules.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Website: drewby.com
Twitter: twitter.com/drewrobbins
All ideas are for information purposes only. I may or may not invest in the stocks discussed. Before investing in any stock, do your research and trade using your rules.
Twitter: twitter.com/drewrobbins
All ideas are for information purposes only. I may or may not invest in the stocks discussed. Before investing in any stock, do your research and trade using your rules.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.